Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Chun Hsu

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Journal of Clinical Medicine|November 27, 2021
Real-World Experience of Chronic Hepatitis C-Related Compensated Liver Cirrhosis Treated with Glecaprevir/Pibrentasvir: A Multicenter Retrospective StudyPei-Yuan Su, Yang-Yuan Chen, Jun-Hung Lai, et al.
Frontiers in Cardiovascular Medicine|March 24, 2023
Artificial intelligence-enabled electrocardiographic screening for left ventricular systolic dysfunction and mortality risk predictionYu-Chang Huang, Yu-Chun Hsu, Zhi-Yong Liu, et al.
Frontiers in Cardiovascular Medicine|November 15, 2023
Machine learning-based prediction of acute mortality in emergency department patients using twelve-lead electrocardiogramPo-Cheng Chang, Zhi-Yong Liu, Yu-Chang Huang, et al.
Clinical and Molecular Hepatology|August 29, 2020
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairmentDesmond Y H Yap, Kevin S H Liu, Yu-Chun Hsu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 3, 2016
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infectionJia-Horng Kao, Rong-Nan Chien, Ting-Tsung Chang, et al.
Journal of Gastroenterology and Hepatology|February 5, 2016
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virusWan-Long Chuang, Rong-Nan Chien, Cheng-Yuan Peng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2021
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks PosttreatmentChun Jen Liu, I Shyan Sheen, Chi Yi Chen, et al.
Infectious Diseases and Therapy|April 9, 2025
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study)Chung-Feng Huang, Jeong Heo, Rong-Nan Chien, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Journal of Clinical Medicine|November 27, 2021
Real-World Experience of Chronic Hepatitis C-Related Compensated Liver Cirrhosis Treated with Glecaprevir/Pibrentasvir: A Multicenter Retrospective StudyPei-Yuan Su, Yang-Yuan Chen, Jun-Hung Lai, et al.
Frontiers in Cardiovascular Medicine|March 24, 2023
Artificial intelligence-enabled electrocardiographic screening for left ventricular systolic dysfunction and mortality risk predictionYu-Chang Huang, Yu-Chun Hsu, Zhi-Yong Liu, et al.
Frontiers in Cardiovascular Medicine|November 15, 2023
Machine learning-based prediction of acute mortality in emergency department patients using twelve-lead electrocardiogramPo-Cheng Chang, Zhi-Yong Liu, Yu-Chang Huang, et al.
Clinical and Molecular Hepatology|August 29, 2020
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairmentDesmond Y H Yap, Kevin S H Liu, Yu-Chun Hsu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 3, 2016
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infectionJia-Horng Kao, Rong-Nan Chien, Ting-Tsung Chang, et al.
Journal of Gastroenterology and Hepatology|February 5, 2016
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virusWan-Long Chuang, Rong-Nan Chien, Cheng-Yuan Peng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2021
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks PosttreatmentChun Jen Liu, I Shyan Sheen, Chi Yi Chen, et al.
Infectious Diseases and Therapy|April 9, 2025
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study)Chung-Feng Huang, Jeong Heo, Rong-Nan Chien, et al.
Pageof 8